Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Report Type

Organization

Disposition

Year

Month

Found 72721 record(s)

Req # A-2020-000331

Adverse Reaction Report (AER) for GAMMAGARD LIQUID. Report numbers: 000732489, 000733136, 000733265, E2B_02891437, 000732400, 000732471, 000732691, 000734265, 000734399, 000735637, 000734267, 000734378, 000734458, 000735152, 000735160, 000735210.

Organization: Health Canada

47 page(s)
July 2020

Req # A-2020-000344

Adverse Reaction Report (AER) for BLUE V. Report number: E2B_03021287.

Organization: Health Canada

9 page(s)
July 2020

Req # A-2020-000353

Adverse Reaction Report (AER) for DOCUSATE SODIUM. Report number: 728535.

Organization: Health Canada

4 page(s)
July 2020

Req # A-2020-000355

Adverse Reaction Report (AER) for LEFLUNOMIDE. Report numbers: E2B_02951932, E2B_02956171, E2B_02829935, E2B_02078745, E2B_02965004, E2B_02968275, E2B_02968785, E2B_02448679, E2B_02865025, E2B_02830324, E2B_02830332, E2B_02830372, E2B_02830412,…

Organization: Health Canada

341 page(s)
July 2020

Req # A-2020-000356

Adverse Reaction Report (AER) for INSULIN GLULISINE. Report number: 000728734.

Organization: Health Canada

4 page(s)
July 2020

Req # A-2020-000359

Adverse Reaction Report (AER) for PSEUDOEPHEDRINE HYDROCHLORIDE. Report number: E2B_02563837.

Organization: Health Canada

7 page(s)
July 2020

Req # A-2020-000361

Adverse Reaction Report (AER) for METOLAZONE. Report number: E2B_02690659.

Organization: Health Canada

8 page(s)
July 2020

Req # A-2020-000403

Adverse Reaction Report (AER) for BENYLIN. Report numbers: 000031564, 000037616, 000037617, 000037618, 000037619, 000052518, 000053609, 000106878, 000116200, 000148393, 000160688, 000169067, 000198934, 000224665, 000334536, 000347070, 000361308,…

Organization: Health Canada

101 page(s)
July 2020

Req # A-2020-000405

Adverse Reaction Report (AER). Report numbers: 000736843, 000737873, 000910881, 000910985.

Organization: Health Canada

34 page(s)
July 2020

Req # A-2020-000414

Adverse Reaction Report (AER) for MOTRIN. Report numbers: 000000692, 000001078, 000001225, 000003408, 000003494, 000004043, 000004895, 000004922, 000006288, 000006551, 000008183, 000008561.

Organization: Health Canada

92 page(s)
July 2020
Date modified: